Related Experiment Video
Updated: Feb 11, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Upregulation of the aging related LMNA splice variant progerin in dilated cardiomyopathy
Moritz Messner1, Santhosh Kumar Ghadge1, Valentina Goetsch1
1Medical University Innsbruck, Department of Internal Medicine III, Cardiology and Angiology, Innsbruck, Tirol, Austria.
Insights
Progerin, a protein linked to aging, is elevated in dilated cardiomyopathy (DCM) hearts, correlating with heart remodeling and potentially contributing to heart failure progression.
Area of Science:
- Cardiovascular Biology
- Molecular Genetics
- Aging Research
Background:
- Dilated cardiomyopathy (DCM) is a significant cause of heart failure, with LMNA gene mutations implicated in 6-8% of cases.
- Hutchinson-Gilford syndrome (HGPS) arises from LMNA mutations, causing progerin accumulation and premature aging.
- Progerin is present at low levels in healthy individuals and associated with aging.
Purpose of the Study:
- To investigate the role of progerin in the pathogenesis of dilated cardiomyopathy.
- To analyze progerin mRNA and protein expression in human DCM hearts and blood.
Main Methods:
- Quantified progerin mRNA in heart tissue and blood from DCM patients and controls using sequencing.
- Performed linear regression to correlate progerin levels with cardiac function (ejection fraction, left ventricular diameter).
- Utilized immunohistochemistry and immunofluorescence to assess progerin protein expression and apoptosis in heart tissue.
Main Results:
- Progerin mRNA was significantly upregulated in DCM hearts compared to controls.
- Heart progerin mRNA levels negatively correlated with ejection fraction and positively with left ventricular end-diastolic diameter.
- Increased progerin protein expression in DCM hearts was associated with heightened cellular apoptosis.
Conclusions:
- Progerin is upregulated in human DCM hearts and linked to left ventricular remodeling.
- Progerin may play a role in the progression of heart failure and myocardial aging.
Background:
Mutations in the LMNA gene are a common cause (6-8%) of dilated cardiomyopathy (DCM) leading to heart failure, a growing health care problem worldwide. The premature aging disease Hutchinson-Gilford syndrome (HGPS) is also caused by defined mutations in the LMNA gene resulting in activation of a cryptic splice donor site leading to a defective truncated prelamin A protein called progerin. Low levels of progerin are expressed in healthy individuals associated with ageing. Here, we aimed to address the role of progerin in dilated cardiomyopathy.
Methods And Results:
mRNA expression of progerin was analyzed in heart tissue of DCM (n = 15) and non-failing hearts (n = 10) as control and in blood samples from patients with DCM (n = 56) and healthy controls (n = 10). Sequencing confirmed the expression of progerin mRNA in the human heart. Progerin mRNA levels derived from DCM hearts were significantly upregulated compared to controls (1.27 ± 0.42 vs. 0.81 ± 0.24; p = 0.005). In contrast, progerin mRNA levels in whole blood cells were not significantly different in DCM patients compared to controls. Linear regression analyses revealed that progerin mRNA in the heart is significantly negatively correlated to ejection fraction (r = -0.567, p = 0.003) and positively correlated to left ventricular enddiastolic diameter (r = 0.551, p = 0.004) but not with age of the heart per se. Progerin mRNA levels were not influenced by inflammation in DCM hearts. Immunohistochemistry and Immunofluorescence analysis confirmed increased expression of progerin protein in cell nuclei of DCM hearts associated with increased TUNEL+ apoptotic cells.
Conclusion:
Our data suggest that progerin is upregulated in human DCM hearts and strongly correlates with left ventricular remodeling. Progerin might be involved in progression of heart failure and myocardial aging.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
RNA Splicing
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy

